MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

Title
MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
Authors
Keywords
ovarian cancer, cisplatin, chemoresisitance, miR-770-5p, ERCC2
Journal
Oncotarget
Volume 7, Issue 33, Pages -
Publisher
Impact Journals, LLC
Online
2016-07-20
DOI
10.18632/oncotarget.10736

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now